HNN3.0

IGES Italy Pharma Consulting SRL

Company (SME)

pharma.iges.com/Milan, Italy
1 profile visit

About

IGES Italy Pharma Consulting is part of the IGES/Athagoras Group, employing experts across Europe with backgrounds in strategy, life sciences, health economics,  commercial, and more. We offer a multidisciplinary, comprehensive market entry approach, including market landscape, opportunity assessment, market access strategy, stakeholder mapping, HTA, business plan, pricing & reimbursement strategy, commercial/organizational and exploitation plan, EU expansion along all product lifecycle.

Representatives

General Manager

IGES Italy Pharma Consulting SRL

Marketplace (1)

  • Project cooperation

    IGES Capabilities in Business Strategy and Market Access for Life Science

    IGES provides tailored market access solutions and full-service product launches for the life science industry in Europe.

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    Author

    General Manager at IGES Italy Pharma Consulting SRL

    Milan, Italy